Overview
XRAY market data
Price History
XRAY price chart · 1M
- O
- 10.92
- H
- 11.25
- L
- 10.89
- C
- 11.04
- Vol
- 223,235.00
- Source
- US equities market feed
- Observed
- Aug 27, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $10.92
- Previous Close
- $10.93
- Day High
- $11.25
- Day Low
- $10.89
- 52 Week High
- $14.43
- 52 Week Low
- $9.41
- 7 Day Return
- +2.51%
- 30 Day Return
- -18.16%
- 90 Day Return
- +5.54%
- 1 Year Return
- -3.75%
- Daily Notional Volume
- $2.5M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$3.00 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.85 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 5.5% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -15.0% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $9.41 – $14.86 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $2.3B · P/B 1.70 · P/S 0.63.
Company News
Barclays Maintains Underweight on Dentsply Sirona, Raises Price Target to $11Benzinga · Aug 24, 2026, 2:17 PM
Dentsply Sirona's Wellspect HealthCare Announces U.S. Launch Of Surity Urinary Management System, Completing Surity External Catheter PortfolioBenzinga · Aug 19, 2026, 12:32 PM
8-K/A filing — DENTSPLY SIRONA Inc. (XRAY)SEC EDGAR · Aug 7, 2026, 11:42 AM
Dentsply Sirona Affirms FY2026 Adj EPS Guidance of $1.40-$1.50 vs $1.42 Est; Affirms FY2026 Sales Guidance of $3.500B-$3.600B vs $3.582B EstBenzinga · Aug 6, 2026, 8:08 PM
Dentsply Sirona Q2 Adj. EPS $0.52 Beats $0.35 Estimate, Sales $898.000M Beat $889.810M EstimateBenzinga · Aug 6, 2026, 8:04 PM
Piper Sandler Maintains Neutral on Dentsply Sirona, Raises Price Target to $14Benzinga · Jul 29, 2026, 5:17 PM
Dentsply Sirona Announces Expanded Relationship With Medline Sinclair To Distribute Its Technology Portfolio Across Canada Effective September 1Benzinga · Jul 28, 2026, 12:34 PM
BMO Capital Initiates Coverage On Dentsply Sirona with Market Perform Rating, Announces Price Target of $12Benzinga · Jul 9, 2026, 2:30 PM
Global Dental Imaging Equipment Market to Reach USD 4.74 Billion by 2031, Driven by Technological AdvancementsGlobenewswire Inc · Jul 3, 2026, 11:00 AM
DENTSPLY SIRONA Appoints John Forston CFO, Effective July 20Benzinga · Jun 11, 2026, 12:33 PM